Retinoic acid (RA): An inhibitor of 5α-reductase in human prostatic cancer cells

[1]  K. Tveter,et al.  Metabolism of androgens in the seminal vesicles and the different lobes of the prostate in young mature rats. , 1985, Journal of steroid biochemistry.

[2]  J. Gustafsson,et al.  Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐r , 1985, The Prostate.

[3]  A. Sunde,et al.  Rapid analysis of C19-steroid metabolism by high-performance liquid chromatography and in-line monitoring of radioactivity. , 1998, Journal of chromatography.

[4]  K L Albright,et al.  Membrane origin for a signal eliciting a program of cell differentiation. , 1984, Experimental cell research.

[5]  D. S. Goodman.  Vitamin A and retinoids in health and disease. , 1984, The New England journal of medicine.

[6]  A. Jetten.  Modulation of cell growth by retinoids and their possible mechanisms of action. , 1984, Federation proceedings.

[7]  R. Marks,et al.  The effects of a novel potent oral retinoid (Rol3-6298) in the treatment of multiple solar keratoses and squamous cell epithelioma. , 1983, European journal of cancer & clinical oncology.

[8]  M. Taketo,et al.  Effects of arotinoids upon murine embryonal carcinoma cells. , 1983, Cancer research.

[9]  F. Labrie,et al.  New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens , 1983, The Prostate.

[10]  R. Lotan,et al.  Sensitivity of cultured human osteosarcoma and chondrosarcoma cells to retinoic acid. , 1982, Cancer research.

[11]  P. Ofner,et al.  Comparative C19‐Radiosteroid Metabolism in Primary Monolayer Cultures of Epithelial Cells and Fibroblasts from Rat Ventral Prostate, Canine Prostate, and Rat Lung , 1982 .

[12]  D. Alberts,et al.  Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. , 1982, Cancer treatment reports.

[13]  G. Rustin,et al.  Trial of an aromatic retinoid in patients with solid tumours. , 1982, British Journal of Cancer.

[14]  J. Lechner,et al.  Growth control of prostatic carcinoma cells in serum-free media: interrelationship of hormone response, cell density, and nutrient media. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Collins,et al.  Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .

[16]  M. Sherman,et al.  Isolation and characterization of mouse mutant embryonal carcinoma cells which fail to differentiate in response to retinoic acid. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Hafez.  Quantitative Physiopathology of Prostatic Carcinoma , 1981 .

[18]  L. Nyberg,et al.  Overview of past and current philosophy of prostatic cancer , 1980, The Prostate.

[19]  M. Sporn,et al.  Chemoprevention of cancer with retinoids. , 1979, Federation proceedings.

[20]  D. Chopra,et al.  Effect of Retinoids and Estrogens on Testosterone-Induced Hyperplasia of Mouse Prostate Explants in Organ Culture 1 , 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  J. Lechner,et al.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.

[22]  I. Lasnitzki.  Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogues. , 1976, British Journal of Cancer.

[23]  A. Roy.  The steroid 5 -reductase activity of rat liver and prostate. , 1971, Biochimie.

[24]  S. Wolbach,et al.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN , 1925, The Journal of experimental medicine.